Fig. 2
From: Enhanced antimicrobial efficacy of hydroxyapatite-based composites for healthcare applications
Volume fraction differences (%) and cumulative fractions (%) of the synthesized pristine HAp (a), and 10% (b, c, and d) of Cu/HAp, Zn/HAp, and Ag/HAp, respectively.
